Annual report

Period2023-01-01 → 2023-12-31
Filed2024-03-12
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 155
MetricValuePeriodScopeSource row
Revenue¥442.2bn2023-01-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥398.4bn2022-01-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥352.2bn2021-01-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥318.4bn2020-01-01 → 2020-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥305.8bn2019-01-01 → 2019-12-31dCons.Revenue IFRS (5-year summary)
Profit before tax¥97.2bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥67.6bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥60.0bn2021-01-01 → 2021-12-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥52.3bn2020-01-01 → 2020-12-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥44.5bn2019-01-01 → 2019-12-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥81.2bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥53.6bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥52.3bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥47.0bn2020-01-01 → 2020-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥67.1bn2019-01-01 → 2019-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥81.2bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥53.6bn2022-01-01 → 2022-12-31Cons.Profit loss IFRS
Total assets¥1.03Tat 2023-12-31Cons.Assets IFRS
Total assets¥939.9bnat 2022-12-31Cons.Assets IFRS
Total assets¥921.9bnat 2021-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥801.3bnat 2020-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥784.5bnat 2019-12-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥189.5bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥177.1bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥836.4bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥762.8bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥737.2bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥836.4bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥762.8bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥737.2bnat 2021-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥698.4bnat 2020-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥678.3bnat 2019-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥403.1bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥339.2bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥335.1bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥287.0bnat 2020-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥20.8bnat 2019-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥115.6bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥48.7bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥86.5bn2021-01-01 → 2021-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥39.5bn2020-01-01 → 2020-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥53.7bn2019-01-01 → 2019-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥20.4bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.2bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥11.4bn2021-01-01 → 2021-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥252.6bn2020-01-01 → 2020-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥933m2019-01-01 → 2019-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥32.5bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥29.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥28.4bn2021-01-01 → 2021-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥26.0bn2020-01-01 → 2020-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥47.4bn2019-01-01 → 2019-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥151.032023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥99.682022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥97.432021-01-01 → 2021-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥87.562020-01-01 → 2020-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥124.572019-01-01 → 2019-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥151.012023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥99.662022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥97.392021-01-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥87.52020-01-01 → 2020-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥124.462019-01-01 → 2019-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,555.81at 2023-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,419.27at 2022-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,371.9at 2021-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,300.12at 2020-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥1,263.16at 2019-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio81.5%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio81.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio80.0%at 2021-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio87.2%at 2020-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio86.5%at 2019-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE10.2%2023-01-01 → 2023-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE7.1%2022-01-01 → 2022-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE7.3%2021-01-01 → 2021-12-31dCons.Rate of return on equity IFRS (5-year summary)
ROE6.8%2020-01-01 → 2020-12-31dCons.Rate of return on equity IFRS (5-year summary)
ROE10.1%2019-01-01 → 2019-12-31dCons.Rate of return on equity IFRS (5-year summary)
Employees5,974at 2023-12-31Cons.Number of employees
Employees5,982at 2022-12-31Cons.Number of employees
Employees5,752at 2021-12-31dCons.Number of employees
Employees5,423at 2020-12-31dCons.Number of employees
Employees5,267at 2019-12-31dCons.Number of employees
Revenue¥277.2bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥253.8bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥237.6bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥252.9bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥246.3bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income¥53.4bn2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥40.6bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income¥67.2bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥37.3bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥35.2bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥49.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥73.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥61.5bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥38.0bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income¥50.4bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥31.0bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥66.4bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥31.3bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income¥91.5bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥869.6bnat 2023-12-31StandaloneAssets
Total assets¥806.1bnat 2022-12-31StandaloneAssets
Total assets¥794.1bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥687.7bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥618.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥246.9bnat 2023-12-31StandaloneLiabilities
Total liabilities¥204.1bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥622.7bnat 2023-12-31StandaloneNet assets
Net assets / equity¥601.9bnat 2022-12-31StandaloneNet assets
Net assets / equity¥596.9bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥555.7bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥549.0bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥12.4bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥11.3bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥93.72023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥57.772022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.522021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥58.182020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥169.852019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥93.692023-01-01 → 2023-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥57.752022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥123.472021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥58.152020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥169.712019-01-01 → 2019-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥562023-01-01 → 2023-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥512022-01-01 → 2022-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥462021-01-01 → 2021-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥442020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥422019-01-01 → 2019-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,158.1at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,119.48at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,110.13at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,033.43at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,021.09at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio71.6%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.6%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio75.1%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.7%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio88.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE8.2%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE5.2%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE11.1%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE5.7%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE17.4%2019-01-01 → 2019-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued540,000,000at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued540,000,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued540,000,000at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued540,000,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued540,000,000at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees4,082at 2023-12-31StandaloneNumber of employees
Employees4,002at 2022-12-31StandaloneNumber of employees
Employees3,857at 2021-12-31dStandaloneNumber of employees
Employees3,736at 2020-12-31dStandaloneNumber of employees
Employees3,619at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceuticalsreportable segmentemployeesat 2023-12-315974 pure
Pharmaceuticalsreportable segmentemployeesat 2023-12-314082 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,826
ItemContextValueUnit
Total shareholder returnPrior2YearInstant_NonConsolidatedMember1.573
Total shareholder returnPrior1YearInstant_NonConsolidatedMember1.542
Total shareholder returnCurrentYearInstant_NonConsolidatedMember1.256
Total return on share price indexPrior4YearInstant_NonConsolidatedMember1.181
Total return on share price indexPrior3YearInstant_NonConsolidatedMember1.268
Total return on share price indexPrior2YearInstant_NonConsolidatedMember1.430
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.395
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.789
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00816-000PharmaceuticalsReportableSegmentMember5974
Number of employeesCurrentYearInstant5974
Number of employeesCurrentYearInstant_NonConsolidatedMember4082
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember43.0
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember16.5
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember9447246JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00816-000PharmaceuticalsReportableSegmentMember4082
Number of employeesCurrentYearInstant_NonConsolidatedMember4082
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E00816-000PharmaceuticalsReportableSegmentMember72100000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration16482000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember540000000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember540000000
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant540000000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant540000000
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember-
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember64
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember48
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember499
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember697
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember64
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember33012
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember34384
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember-
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember978287
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember168483
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember2950055
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember901229
Number of shares held number of units foreign individual investorsCurrentYearInstant_OrdinaryShareMember445
Number of shares held number of units individuals and othersCurrentYearInstant_OrdinaryShareMember396430
Number of shares held number of units totalCurrentYearInstant_OrdinaryShareMember5394929
Number of shares held shares less than one unitCurrentYearInstant_OrdinaryShareMember507100
Percentage of shareholdings national and local governmentsCurrentYearInstant_OrdinaryShareMember-
Percentage of shareholdings financial institutionsCurrentYearInstant_OrdinaryShareMember0.1813
Percentage of shareholdings financial service providersCurrentYearInstant_OrdinaryShareMember0.0312
Percentage of shareholdings other corporationsCurrentYearInstant_OrdinaryShareMember0.5468
Percentage of shareholdings foreigners other than individualsCurrentYearInstant_OrdinaryShareMember0.1671
Percentage of shareholdings foreign individualsCurrentYearInstant_OrdinaryShareMember0.0001
Percentage of shareholdings individuals and othersCurrentYearInstant_OrdinaryShareMember0.0735
Number of shares heldCurrentYearInstant_No1MajorShareholdersMember288819000
Shareholding ratioCurrentYearInstant_No1MajorShareholdersMember0.5372
Number of shares heldCurrentYearInstant_No2MajorShareholdersMember58462000

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass